Rebecca J. Fairclough
AstraZeneca (United Kingdom)(GB)
Publications by Year
Research Areas
Muscle Physiology and Disorders, Nerve injury and regeneration, Virus-based gene therapy research, Genetic and rare skin diseases., Pancreatic function and diabetes
Most-Cited Works
- → Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches(2013)222 cited
- → Daily Treatment with SMTC1100, a Novel Small Molecule Utrophin Upregulator, Dramatically Reduces the Dystrophic Symptoms in the mdx Mouse(2011)172 cited
- → The Secretory Pathway Ca2+/Mn2+-ATPase 2 Is a Golgi-localized Pump with High Affinity for Ca2+ Ions(2005)132 cited
- → Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease(2004)129 cited
- → Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2(2010)125 cited
- → Effect of Hailey-Hailey Disease Mutations on the Function of a New Variant of Human Secretory Pathway Ca2+/Mn2+-ATPase (hSPCA1)(2003)104 cited
- → Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin(2010)97 cited
- → Hailey-Hailey Disease: Molecular and Clinical Characterization of Novel Mutations in the ATP2C1 Gene(2002)92 cited
- → 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial(2020)68 cited
- → Progress in therapy for Duchenne muscular dystrophy(2011)63 cited